Literature DB >> 6477272

Changing patterns of failure in advanced head and neck cancer.

B Vikram.   

Abstract

We treated 98 previously untreated patients with stages III and IV resectable epidermoid carcinoma of the oral cavity, oropharynx, and larynx with surgery and postoperative radiation therapy. The reasons for postoperative radiation therapy were unsatisfactory surgical margins in 36 patients, cervical metastases at multiple levels pathologically in 49, and both in 13. Historically, patients with similar findings, treated by surgery alone at our institution, had a relapse rate above the clavicles of more than 70% within two years. In the present series only 15% have had relapses above the clavicles, and distant metastases developed in another 20%. In addition, approximately 6% of patients per year have had second malignant neoplasms develop, predominantly in the esophagus or the lung. These changes in the patterns of failure have implications for future studies aimed at improving the cure rate and the survival of these patients.

Entities:  

Mesh:

Year:  1984        PMID: 6477272     DOI: 10.1001/archotol.1984.00800350006003

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  22 in total

1.  Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Snehal G Patel; Richard B Hayes; Ian Ganly
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

2.  Therapeutic outcome after resection of pulmonary metastasis from head and neck carcinomas.

Authors:  Keisuke Yamazaki; Ryusuke Shodo; Yushi Ueki; Hiroshi Matsuyama; Sugata Takahashi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-15

3.  Causes of death in long-term survivors of head and neck cancer.

Authors:  Shrujal S Baxi; Laura C Pinheiro; Sujata M Patil; David G Pfister; Kevin C Oeffinger; Elena B Elkin
Journal:  Cancer       Date:  2014-02-22       Impact factor: 6.860

4.  Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Authors:  Aarti K Bhatia; Ju-Whei Lee; Harlan A Pinto; Charlotte D Jacobs; Paul J Limburg; Philip Rubin; Robert M Arusell; Eamonn P Dunphy; Janardan D Khandekar; Seth A Reiner; Luis Baez-Diaz; Paul Celano; Shuli Li; Yi Li; Barbara A Burtness; George L Adams; Kishan J Pandya
Journal:  Cancer       Date:  2017-08-07       Impact factor: 6.860

5.  Are autopsies useful? Do premorbid findings predict postmortem results in head and neck cancer patients?

Authors:  C R Jennings; P J Bradley
Journal:  Ann R Coll Surg Engl       Date:  2002-03       Impact factor: 1.891

6.  Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.

Authors:  Lin Wang; Zhien Feng; Huanhuan Wu; Shuai Zhang; Yinfei Pu; Huan Bian; Yixiang Wang; Chuanbin Guo
Journal:  Tumour Biol       Date:  2014-08-05

Review 7.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer.

Authors:  S P Bugis; E Lotzová; H E Savage; J P Hester; T Racz; P G Sacks; S P Schantz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.

Authors:  Lisheng Ge; Dejan Baskic; Per Basse; Lazar Vujanovic; Sebnem Unlu; Toshie Yoneyama; Andrea Vujanovic; Jie Han; Dragic Bankovic; Miroslaw J Szczepanski; Jennifer L Hunt; Ronald B Herberman; Susanne M Gollin; Robert L Ferris; Theresa L Whiteside; Eugene N Myers; Nikola L Vujanovic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

10.  Second Primary Lung Cancer with Glottic Laryngeal Cancer as Index Tumor - A Case Report.

Authors:  Jamal Akhtar; Rakesh Bhargava; Mohammad Shameem; Saurabh K Singh; Ummul Baneen; Nafees Ahmad Khan; Jassem Hassan; Prakhar Sharma
Journal:  Case Rep Oncol       Date:  2010-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.